首页 | 本学科首页   官方微博 | 高级检索  
     

KAI1和CD44v6蛋白在骨肉瘤组织中的表达及临床意义
作者单位:Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  
摘    要:


关 键 词:CD44v6蛋白  KAI1基因  人骨肉瘤  临床意义  Enneking  CD44v6表达  外科分期系统  Cox模型分析

The expression and clinical significance of KAI1 and CD44v6 protein in human osteosarcoma
Weihua Hu,Anmin Chen,Fengjing Guo,Feng Li. The expression and clinical significance of KAI1 and CD44v6 protein in human osteosarcoma[J]. The Chinese-German Journal of Clinical Oncology, 2009, 8(4): 232-236. DOI: 10.1007/s10330-009-0024-8
Authors:Weihua Hu  Anmin Chen  Fengjing Guo  Feng Li
Affiliation:Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Abstract:
Objective: To investigate the expressions of KAI1 and CD44v6 in human osteosarcoma and the relationship between expressions of them and their clinic pathological features and prognosis. Methods: The expressions of KAI1 and CD44v6 in 87 samples with osteosarcema were detected by S-P immunohistochemistry. Results: Expression of KAI1 had correlation with metastasis of osteosarcoma, and was strongly associated with differentiation of tumor cells. The expression of CD44v6 in osteosarcoma had correlation with metastasis. There was no difference between the expression of KAI1 and CD44v6. Cox model analysis showed that the prognostic factors were KAI1 expression, metastasis and Enneking surgical staging system. Conclusion: The abnormal expression of KAI1 and CD44v6 participate metastasis of osteosarcoma, KAI1 expression, metastasis and Enneking surgical staging system can be used to independently predict the prognosis of osteo-sarcoma patients.
Keywords:KAI1  CD44v6  osteosarcoma  metastasis
本文献已被 维普 万方数据 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号